Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,710 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

NCT03342144

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Universitaetsklinikum St. Poelten /ID# 221152 Sankt Pölten, Lower Austria, Austria
  • Medizinische Universitaet Graz /ID# 221155 Graz, Styria, Austria
  • Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153 Salzburg, Austria
  • Hanusch Krankenhaus /ID# 221151 Vienna, Austria
View all 72 locations
View Trial Details
Recruiting

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

NCT05748171

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques universitaires Saint-Luc Brussels, Bruxelles-capitale, Région de, Belgium
  • UZ Gent Ghent, Oost-vlaanderen, Belgium
  • UZ Leuven Leuven, Vlaams-brabant, Belgium
View all 65 locations
View Trial Details
Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

NCT07504458

Conditions
Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia, Acute Promyelocytic Leukemia (APL), +12 more
Locations
  • Quetzal Site 1 Duarte, California, United States
  • Quetzal Site 7 Los Angeles, California, United States
  • Quetzal Site 5 Stanford, California, United States
  • Quetzal Site 4 Buffalo, New York, United States
View all 28 locations
View Trial Details
Recruiting

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

NCT06824168

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • John Hopkins School of Medicine Baltimore, Maryland, United States
  • Umass Memorial Health Care Systems Worcester, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Weill Cornell New York, United States
View all 64 locations
View Trial Details

Related conditions